<?xml version='1.0' encoding='utf-8'?>
<?xml-stylesheet type="text/xsl" href="/v2/static/oai2.xsl"?>
<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2026-10-12T16:13:51Z</responseDate>
  <request identifier="oai:figshare.com:article/32639547" metadataPrefix="oai_dc" verb="GetRecord">https://api.figshare.com/v2/oai</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:figshare.com:article/32639547</identifier>
        <datestamp>2026-10-01T16:39:12Z</datestamp>
        <setSpec>portal_1172</setSpec>
        <setSpec>item_type_8</setSpec>
        <setSpec>month_year_10_2026</setSpec>
      </header>
      <metadata>
        <oai_dc:dc xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"  xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
          <dc:title>Identification of natural antimicrobial peptides from amphibians: structural modification for bioactivity development</dc:title>
          <dc:creator>Weining Yin (3862687)</dc:creator>
          <dc:subject>PUREID: 588605509</dc:subject>
          <dc:subject>Antimicrobial peptide</dc:subject>
          <dc:subject>anti-cancer peptide</dc:subject>
          <dc:subject>Phylloseptin</dc:subject>
          <dc:description>The vastness of nature has been the source of medicine for humanity since ancient times, and the diversity of
natural products brings continuous inspiration for drug research and development. This study targeted
antimicrobial peptides (AMPs) in the skin secretions of frogs from the Phyllomedusa genus, to explore their
activities, functions, and the effects of structure on activities of component AMPs and to provide high-quality
candidates for more far-reaching drug development.
In Chapter 3, PSTO2 showed excellent bacteriostatic activity and sterilization function under multiple
antibacterial experiments, with high bactericidal speed and efficiency. In addition, PSTO2 also exhibited
significant cancer cell inhibitory activity and could harm tumour cells through various mechanisms, including
damage to cell membranes and induction of apoptosis. Moreover, in safety and toxicity tests, PSTO2 showed
relatively low toxicity in vivo and in vitro. Therefore, PSTO2 has been proven to be an effective AMP with
multiple functions and high safety, which has good potential for bacterial control and cancer drug development.
In Chapter 4, eight analogues of PSTO2 were designed according to different structural characteristics and
amino acid compositions, and their antibacterial, anti-biofilm, and anti-cancer activities were tested. According
to the results, SRD7 had the highest comprehensive therapeutic index, has a particularly outstanding
therapeutic effect and killing rate against Gram-positive bacteria, and can significantly destroy cell membranes.
It thus has a significant impact on overcoming drug resistance. Also, this peptide showed higher salt ion and
serum stability and safety, making it an excellent candidate for development as an alternative antibiotic agent.
In Chapter 5, eight analogues were designed based on DSH2, an existing AMP derived from the skin
secretions of another frog from the Phyllomedusa genus (Phyllomedusa hypochondria). Among the modified
analogues, DW exhibited the most prominent therapeutic index, with intense antibacterial and anticancer
activity as well as low toxicity. Therefore, increasing the hydrophobic and hydrophilic amino acid distribution of
DSH2 enhanced its antibacterial and anticancer effects. Due to its efficacy in treating ESKAPE biofilm
infections, and various high-risk cancer cells, DW has the potential to become a novel antibacterial and
anticancer drug lead. &lt;br&gt;&lt;i&gt;&lt;br&gt;Thesis is embargoed until 31 July 2029.&lt;/i&gt;</dc:description>
          <dc:date>2026-10-01T16:39:12Z</dc:date>
          <dc:type>Text</dc:type>
          <dc:type>Thesis</dc:type>
          <dc:identifier>10.17034/32639547.v1</dc:identifier>
          <dc:relation>https://figshare.com/articles/thesis/Identification_of_natural_antimicrobial_peptides_from_amphibians_structural_modification_for_bioactivity_development/32639547</dc:relation>
          <dc:rights>All Rights Reserved</dc:rights>
          <dc:rights>Open Access after 2029-07-31</dc:rights>
        </oai_dc:dc>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
